IC51 (IXIARO, JESPECT)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IC51 (IXIARO, JESPECT), covering 2014-12-19 to 2014-12-19. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic Countries [Phase 3]